We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The list of observations noted below document that the Quality Unit has not performed the necessary assessments/reviews to ensure that the objectionable conditions do not negatively affect the aseptic manufacturing processes and Quality Control tests in support of the finished sterile drug products.